AGENDA
SYMPOSIUM ON RECENT TOPICS IN CANCER RESEARCH
Osaka, Japan, June 12 and 13, 1980
| Organizers: | Dr. Robert W. Miller Dr. Haruo Sugano Dr. Yuichi Yamamura Dr. Takashi Sugimura Dr. Yoshio Sakurai |
| Thursday, June 12 | ||
| OPENING SESSION | ||
| 9:00- 9:05am | Welcoming Address | Dr. Yuichi Yamamura |
| 9:05- 9:10 | Remarks | Dr. Robert W. Miller |
| STRUCTURE AND FUNCTION OF THE U. S. - JAPAN COOPERATIVE CANCER RESEARCH PROGRAM | ||
| Chairperson: Dr. Yuichi Yamamura | ||
| 9:10- 9:20 | The First Five Years | Dr. Robert R. Omata |
| 9:20- 9:30 | The Second Five Years | Mr. Kichimasa Soda |
| ETIOLOGY PROGRAM AREA | ||
| Chairperson (Session 1): Dr. Takashi Sugimura | ||
| 9:30- 10:00 | Multiple Factors and Interactions in Carcinogenesis | Dr. I. Bernard Weinstein |
| 10:00- 10:15 | Discussion | |
| Chairperson (Session 2): Dr. I. Bernard Weinstein | ||
| 10:15- 10:35 | Naturally Occurring Initiators and Tumor Promoters | Dr. Takashi Sugimura |
| 10:35- 10:45am | Discussion | |
| 10:45- 11:05 | COFFEE | |
| Chairperson (Session 3): Dr. H. Shimojo | ||
| 11:05-11:35 | The Dual Products of the Polyoma Virus HR-T Gene | Dr. Thomas L. Benjamin |
| 11:35-11:50 | Discussion | |
| Chairperson (Session 4): Dr. Thomas L. Benjamin | ||
| 11:50-12:10 pm | The Transforming Genes of Adenovirus Type 12 and Their Functions | Dr. Hiroto Shimojo |
| 12:10- 12:20 | Discussion | |
| 12:20- 1:30 | LUNCH | |
| Chairperson (Session 5): Dr. Thomas L. Benjamin | ||
| 1:30- 1:50 | RNA Tumor Viruses | Dr. Kumao Toyoshima |
| 1:50-2:00 | Discussion | |
| BIOLOGY AND DIAGNOSIS PROGRAM AREA | ||
| Chairperson (Session 1): Dr. Yoji Ikawa | ||
| 2:00- 2:20 | Transfer RNA in Tumor Cells | Dr. Susumu Nishimura |
| 2:20-2:30 | Discussion | |
| Chairperson (Session 2): Dr. Toshiyuki Hamaoka | ||
| 2:30- 3:00 | Natural-killer Cells and Possible In Vivo Role in Resistance to Tumors | Dr. Ronald Herberman |
| 3:00-3:15 | Discussion | |
| 3:15- 3:35 | COFFEE | |
| Chairperson (Sessions 3 and 4): Dr. Ronald Herberman | ||
| 3:35- 3:55 | Augmentation of Tumor-specific Immunity by T-T Cell Interactions and Its Potential Application to Future Tumor-specific Immunotherapy | Dr. Toshiyuki Hamaoka |
| 3:55-4:05 | Discussion | |
| 4:05- 4:25 | New Synthetic Immunopotentiating Agents and Their Antitumor Activities | Dr. Yuichi Yamamura Dr. Ichiro Azuma |
| 4:25-4:35 | Discussion | |
| Chairperson (Session 5): Dr. Yuichi Yamamura | ||
| 4:35- 5:05 | Current Developments in Chromosomes and Cancer | Dr. Warren W. Nichols |
| 5:05-5:20 | Discussion | |
| 5:20 | Adjourn | |
| 6:30-8:30pm | RECEPTION | |
| Friday, June 13 CANCER TREATMENT PROGRAM AREA |
||
| Chairperson (Session 1): Dr. Yoshio Sakurai | ||
| 9:00- 9:30am | Current Concepts of Combined Modality Therapy | Dr. Stephen K. Carter |
| 9:30-9:45 | Discussion | |
| Chairperson (Session 2): Dr. Toyozo Terashima | ||
| 9:45-10:15 | New Developments in Radiation Oncology (i.e., radio-sensitizing drugs, hyperthemia, high LET therapy) | Dr. Glenn E. Sheline |
| 10:15- 10:30 | Discussion | |
| 10:30- 10:50 | COFFEE | |
| Chairperson(Session 3): Dr. Glenn E. Sheline | ||
| 10:50- 11:10 | Radiation-chemo therapeutics Combination In Vitro | Dr. Toyozo Terashima |
| 11:10- 11:20 | Discussion | |
| Chairperson (Session 4): Dr. Makoto Ogawa | ||
| 11:20- 11:50 | New Drugs in Clinical Trial | Dr. Richard S. Ungerleider |
| 11:50- 12:05pm | Discussion | |
| 12:05- 1:10 | LUNCH | |
| Chairperson (Session 5): Dr. Stephen K. Carter | ||
| 1:10- 1:30 | The U.S.-Japan Cooperative Trial in Patients with Disseminated Gastric Cancer Employing a Common Protocol | Dr. Yoshio Sakurai Dr. Makoto Ogawa |
| 1:30-1:40 | Discussion | |
| INTERDISCIPLINARY PROGRAM AREA | ||
| Chairperson (Sessions 1 and 2): Dr. Robert W. Miller | ||
| 1:40- 2:00 | Comparison of Breast Cancer in Japan and the United States | Dr. Haruo Sugano |
| 2:00-2:10 | Discussion | |
| 2:10- 2:30 | Hormone Receptors and Breast Cancer | Dr. Keishi Matsumoto |
| 2:30-2:40 | Discussion | |
| 2:40- 3:00 | COFFEE | |
| Chairperson (Sessions 3 and 4): Dr. Haruo Sugano | ||
| 3:00- 3:20 | Familial Polyposis of the Colon | Dr. Joji Utsunomiya |
| 3:20-3:30 | Discussion | |
| 3:30-4:00 | Recent Developments in the Clinical Etiology of Cancer | Dr. Robert W. Miller |
| 4:00-4:15 | Discussion | |
| 4:15- 4:20 | CLOSING REMARKS | Dr. Robert W. Miller Dr. Haruo Sugano |
PARTICIPANTS
JAPAN
Dr. Ichiro Azuma
Professor, Institute of Immunological Science
Hokkaido University
Kita-ku, Sapporo 060
Dr. Toshiyuki Hamaoka
Professor
Institute for Cancer Research
Osaka University School of Medicine
Fukushima-ku, Osaka 553
Dr. Yoji Ikawa
Member and Chief
Department of Viral Oncology
Cancer Institute
Japanese Foundation for Cancer Research
Toshima-ku, Tokyo 170
Dr. Keishi Matsumoto
Professor, Department of Pathology
Osaka University School of Medicine
Kita-ku, Osaka 530
Dr. Susumu Nishimura
Chief, Biology Division
National Cancer Center Research Institute
Chuo-ku, Tokyo 104
Dr. Makoto Ogawa
Chief, Division of Clinical
Chemotherapy
Cancer Chemotherapy Center
Japanese Foundation for Cancer Research
Toshima-ku, Tokyo 170
Dr. Yoshio Sakurai
Director, Cancer Chemotherapy Center
Japanese Foundation for Cancer Research
Toshima-ku, Tokyo 170
Dr. Hiroto Shimojo
Professor
The Institute of Medical Science
The University of Tokyo
Minato-ku, Tokyo 108
Mr. Kichimasa Soda
Head, Programme Department
Japan Society for the Promotion of Science
Chiyoda-ku, Tokyo 102
Dr. Haruo Sugano
Director, Cancer Institute
Japanese Foundation for Cancer Research
Toshima-ku, Tokyo 170
Dr. Takashi Sugimura
Director, National Cancer Center Research Institute
Chuo-ku, Tokyo 104
Dr. Toyozo Terashima
Deputy Director
National Institute of Radiological Science
Anagawa, Chiba 280
Dr. Kumao Toyoshima
Professor
The Institute of Medical Science
The University of Tokyo
Minato-ku, Tokyo 108
Dr. Joji Utsunomiya
Lecturer, Department of Surgery
Tokyo Medical and Dental University School of Medicine
Bunkyo-ku, Tokyo 113
Dr. Yuichi Yamamura
President
Osaka University
Kita-ku, Osaka 530
UNITED STATES
Dr. Thomas L. Benjamin
Professor, Department of Pathology
Harvard University School of Medicine
Boston, Massachusetts 02115
Dr. Stephen K. Carter
Director
Northern California Cancer Program
1801 Page Mill Road
Building B, Suite 200
Palo Alto, California 94304
Dr. Ronald Herberman
Chief
Laboratory of Imnunodiagnosis
National Cancer Institute
Building 10, Room 8B02
Bethesda, Maryland 20205
Dr. Robert W. Miller
Chief, Clinical Epidemiology Branch
Division of Cancer Cause and Prevention
National Cancer Institute
Bethesda, Maryland 20205
Dr. Warren W. Nichols
Institute for Medical Research
Copewood Street
Camden, New Jersey 08103
Dr. Robert R. Omata
Executive Secretary
U.S.-Japan Cooperative Cancer Research Program
Office of International Affairs
National Cancer Institute
Bethesda, Maryland 20205
Dr. Glenn E. Sheline
Professor and Vice-Chairman
Division of Radiation Oncology
330 Moffitt
University of California Medical Center
San Francisco, California 94143
Dr. Richard S. Ungerleider
Cancer Therapy Evaluation Program
Division of Cancer Treatment
National Cancer Institute
Bethesda, Maryland 20205
Dr. I. Bernard Weinstein
Professor
Institute for Cancer Research
Columbia-Presbyterian Medical Center
630 West 168th Street
New York City. New York 10032